United-Guardian Inc

United-Guardian Inc(UG)股票分析

$6.780

-0.020 (-0.29%)收盤時

Loading chart…
最高
6.885
開盤
6.690
成交量加權均價
6.77
成交量
16.51K
市值
42.64M
最低
6.650
成交金額
111.82K
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

United-Guardian, Inc. is a manufacturer of cosmetic ingredients, sexual wellness ingredients, pharmaceuticals, and medical lubricants. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial.

u-g.com

AI 分析 of United-Guardian Inc (UG)

持有

United-Guardian Inc is currently not a strong buy due to mixed performance indicators. The current price is $6.78, with an RSI of 40.69 indicating a neutral momentum. The forward P/E ratio is 26.53, suggesting that the stock may be overvalued relative to its earnings potential. However, the company has shown a year-to-date change of +10.60%, indicating some resilience. The main risk is the recent revenue decline of 13.5% year-over-year, attributed to market challenges, which could impact future profitability.

估值指標

United-Guardian Inc(UG)目前預期本益比為 26.53,5 年平均預期本益比為 4.61。

預期本益比

嚴重高估
5 年均值 P/E
4.61
目前P/E
26.53
高估
14.78
低估
-5.56

預期 EV/EBITDA

嚴重低估
5 年均值 EV/EBITDA
0.00
目前EV/EBITDA
0.00
高估
0.00
低估
0.00

預期股價營收比

嚴重低估
5 年均值 P/S
0.00
目前P/S
0.00
高估
0.00
低估
0.00

Alphio AI 對 UG 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%UG

$13.06

情境價格

基

基準

基準 · 50%UG

$11.05

情境價格

悲

悲觀

悲觀 · 25%UG

$10.96

情境價格

事件時間軸

2025-11-06 (ET)

09:04:50

United-Guardian Announces Q3 Earnings Per Share of 6 Cents Compared to 19 Cents Last Year

2025-08-08 (ET)

09:05:14

United-Guardian reports Q2 EPS 14c vs 21c

2025-05-21 (ET)

09:05:44

United-Guardian appoints Donna Vigilante to board of directors

2025-05-08 (ET)

09:03:12

United-Guardian reports Q1 EPS 12c vs 20c last year

2025-03-21 (ET)

09:04:32

United-Guardian reports FY24 EPS 71c vs 56c last year

資訊

UG 常見問題 —— 由 Alphio AI 解答

United-Guardian, Inc. is a manufacturer of cosmetic ingredients, sexual wellness ingredients, pharmaceuticals, and medical lubricants. The Company’s product lines include the Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Its four distinct product categories include cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. Its COSMOS line of products includes Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural, and Lubrajel Terra. Its medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. The Company’s pharmaceutical products include an FDA-approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial. It operates in the Healthcare sector (PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS industry).

United-Guardian Inc is currently not a strong buy due to mixed performance indicators. The current price is $6.78, with an RSI of 40.69 indicating a neutral momentum. The forward P/E ratio is 26.53, suggesting that the stock may be overvalued relative to its earnings potential. However, the company has shown a year-to-date change of +10.60%, indicating some resilience. The main risk is the recent revenue decline of 13.5% year-over-year, attributed to market challenges, which could impact future profitability.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易